Close

Share this page

Thailand

Established in 2002, our Thai operations offer an exemplary environment for clinical trials in an emerging market. The country's highly skilled workforce and large treatment population—which covers a broad range of disease profiles, including tropical diseases—makes Thailand an effective location for clinical trials. State-of-the-art medical services and infrastructure are also attractive features when choosing the country for trials.


Fast Facts

Health Expenditure per Capita
(2014, US$)

$360

Source: World Health Organization Global Health Expenditure Database

Life Expectancy at Birth
(2016 est.)

male

71

years

female

78

years

Source: The World Fact Book;
Central Intelligence Agency

Burden of Disease DALYs Causes % of Total DALYs
(2015, all ages/both sexes)

Ischemic heart disease (5.39%)

Cerebrovascular disease (4.97%)

Road injuries (4.7%)

Source: Global Burden of Disease Study 2015;
Institute for Health Metrics and Evaluation

NDA Approval Time

6

months



8

months




Features

Thailand: leading ASEAN in clinical research

In Thailand, clinical research is an emerging industry promoting healthcare innovation and economic prosperity. Of all the countries that make up the Association of Southeast Asian Nations (ASEAN), Thailand leads in clinical research ...

Thailand's struggle with multidrug-resistant falciparum malaria

In 1991, a clinical trial in Thailand was published proving that dosages of oral artesunate at 1200, 600 or 650 mg combined with 480 mg of intramuscular artemether to be an effective treatment for multidrug-resistant falciparum malaria ...


Services Available in Thailand

EPS Global Research (Thailand) Ltd.

Suite 2967L Level 29, The Offices at Centralworld 999/9 Rama I Road, Pathumwan, Bangkok 10330 Thailand
Tel: +66 2 207 8641
Fax: +66 2 207 2626
E-mail: info@epsi-global.com


We will tailor an ideal solution for your specific needs.

Request a Proposal